FDA Approved Products
6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
PAXIL
paroxetine hydrochloride
LOE Approaching
ORAL · CAPSULE
1998
NDA30/100
PAXIL
paroxetine hydrochloride
LOE Approaching
ORAL · TABLET
anxiety
1992
NDA30/100
PAXIL CR
paroxetine hydrochloride
LOE Approaching
ORAL · TABLET, EXTENDED RELEASE
anxiety
1999
NDA30/100
PAXIPAM
halazepam
LOE Approaching
Merck & Co.
ORAL · TABLET
1981
NDA30/100
PBZ
tripelennamine citrate
LOE Approaching
Novartis
ORAL · ELIXIR
1948
NDA30/100
PBZ-SR
tripelennamine hydrochloride
LOE Approaching
Novartis
ORAL · TABLET, EXTENDED RELEASE
1956
NDA30/100
PCE
erythromycin
LOE Approaching
R-Pharm US
ORAL · TABLET, COATED PARTICLES
1986
NDA30/100
PEDIAPRED
prednisolone sodium phosphate
LOE Approaching
ORAL · SOLUTION
the following conditions: 1systemic lupus erythematosus+12
1986
NDA30/100
PEDIATRIC ADVIL
ibuprofen
LOE Approaching
GSK
ORAL · SUSPENSION/DROPS
1998
SMNDA30/100
PEDIAZOLE
erythromycin ethylsuccinate; sulfisoxazole acetyl
LOE Approaching
ORAL · GRANULE
1979
NDA30/100
PEGANONE
ethotoin
LOE Approaching
Recordati
ORAL · TABLET
1957
NDA30/100
PEMETREXED
pemetrexed
Peak
Teva
INTRAVENOUS · SOLUTION
non-small cell lung cancerlung cancer
2020
NDA30/100
PEMETREXED DISODIUM
pemetrexed disodium
Peak
Novartis
INTRAVENOUS · SOLUTION
non-small cell lung cancerlung cancer
2022
NDA30/100
PEMETREXED DISODIUM
pemetrexed
Peak
Pfizer
INTRAVENOUS · SOLUTION
non-small cell lung cancerlung cancer
2022
NDA30/100
PEMETREXED DISODIUM
pemetrexed disodium
Peak
Accord Biopharma
INTRAVENOUS · SOLUTION
2022
NDA30/100
PEMETREXED DITROMETHAMINE
pemetrexed ditromethamine
Peak
Pfizer
INTRAVENOUS · POWDER
2022
NDA30/100
PENBRITIN-S
ampicillin sodium
LOE Approaching
Thayer Medical
INJECTION · INJECTABLE
1966
NDA30/100
PENETREX
enoxacin
LOE Approaching
Sanofi
ORAL · TABLET
1991
SMNDA30/100
PENICILLIN G POTASSIUM IN PLASTIC CONTAINER
penicillin g
LOE Approaching
Baxter
INJECTION · INJECTABLE
the treatment of serious infections caused by susceptible strains of the designated microorganisms in the conditions listed below
1990
NDA30/100
PENLAC
ciclopirox
LOE Approaching
Bausch + Lomb
TOPICAL · SOLUTION
1999
NDA30/100
PENTAM
pentamidine isethionate
LOE Approaching
Fresenius Kabi
INJECTION · INJECTABLE
pneumonia due to Pneumocystis carinii
1984
NDA30/100
PENTASA
mesalamine
LOE Approaching
Takeda
ORAL · CAPSULE, EXTENDED RELEASE
ulcerative colitis
1993
NDA30/100
PENTETATE CALCIUM TRISODIUM
pentetate calcium trisodium
LOE Approaching
INHALATION, INTRAVENOUS · SOLUTION
individuals with knownsuspected internal contamination with plutonium+2
2004
NDA30/100
PENTETATE ZINC TRISODIUM
pentetate zinc trisodium
LOE Approaching
INHALATION, INTRAVENOUS · SOLUTION
individuals with knownsuspected internal contamination with plutonium+2
2004
NDA30/100